Video

Dr. Broghammer on patient selection for treatment with intracavernosal injections

Author(s):

Urology Times staff

Joshua A. Broghammer, MD, discusses the ideal patient population for treatment with intracavernosal injections for erectile dysfunction. Broghammer is an associate professor of Urology at the University of Kansas Medical Center.

Related Videos
Justin Dubin, MD, answers a question during a video interview
Man talking with a doctor | Image Credit: © RFBSIP - stock.adobe.com
Related Content
Men with severe ED more than twice likely to have high ceramide levels
October 18th 2024

Men with severe ED more than twice likely to have high ceramide levels

Kevin Kunzmann
New research better defines the link between cardiovascular disease risk and prevalence of ED per serum ceramide levels.
Dr. Bristol Whiles discusses her experience as a urology resident
July 25th 2022

Dr. Bristol Whiles discusses her experience as a urology resident

Kansas University Department of Urology
On this podcast, Bristol Whiles, MD, discusses her urology residency experience at the Kansas University School of Medicine Department of Urology.
Survey reveals generational trends in men’s health habits
September 5th 2024

Survey reveals generational trends in men’s health habits

Hannah Clarke
“We saw in the survey that men are concerned with how the health decisions they make now will affect them in the future,” says Petar Bajic, MD.
The urologist's role in dispelling men's health myths
May 10th 2022

The urologist's role in dispelling men's health myths

Urology Times staff
“I think it's really important to understand the role of prevention and early detection,” says Michael Lutz, MD.
Novel classification system proposed for Peyronie disease, penile curvature
August 9th 2024

Novel classification system proposed for Peyronie disease, penile curvature

Hannah Clarke
"We propose a new classification system, which we believe will provide a more consistent and standardized approach to classification and treatment of PD," says Landon Trost, MD.
Approval sought for testosterone undecanoate in Canada
July 31st 2024

Approval sought for testosterone undecanoate in Canada

Hannah Clarke
A decision on the NDS for testosterone undecanoate is expected in Q2 of 2025.
© 2024 MJH Life Sciences

All rights reserved.